Abstract
Patterns of global histone modifications have been recently suggested as outcome predictors in cancer patients. To date, there has been no report on the prognostic significance of global histone modifications in esophageal squamous cell carcinoma. We investigated the role of global histone modification as outcome predictor in patients undergoing esophagectomy for esophageal squamous cell carcinoma. A retrospective clinicopathologic analysis was undertaken of 97 patients with esophageal squamous cell carcinoma who recovered from esophagectomy. Immunohistochemical expression of five histone modification markers, acetylated histone 3 lysine 18 (H3K18Ac), acetylated histone 4 lysine 12 (H4K12Ac), dimethylated histone 4 arginine 3 (H4R3diMe), dimethylated histone 3 lysine 4 (H3 K4diMe), and trimethylated histone 3 lysine 27 (H3K27triMe) was assessed in paraffin-embedded tumor samples. Results were analyzed in relation to patients' clinicopathologic parameters. There was a positive relationship between tumor differentiation and H3K18Ac (P
Original language | English |
---|---|
Pages (from-to) | 252-260 |
Number of pages | 9 |
Journal | Modern Pathology |
Volume | 22 |
Issue number | 2 |
DOIs | |
Publication status | Published - Feb 2009 |
Externally published | Yes |
Keywords
- Esophageal squamous cell carcinoma
- Histone modification
- Prognosis
ASJC Scopus subject areas
- Pathology and Forensic Medicine